Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $359.92 billion as of January 23, 2025. Its market cap has decreased by -24.33% in one year.

Market Cap

359.92B

Enterprise Value

357.42B

Revenue

40.47B

Ranking

n/a

PE Ratio

25.41

Stock Price

$82.23

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 359.92B, an increase of 4,936.27%. That is a compound annual growth rate of 15.06%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	360.47B	-6.57%
Dec 30, 2024	385.82B	-16.41%
Dec 29, 2023	461.55B	51.61%
Dec 30, 2022	304.43B	19.34%
Dec 30, 2021	255.09B	56.58%
Dec 30, 2020	162.91B	19.30%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.02B
Veradigm	1.53B
SS Innovations International	1.45B
Nika Pharmaceuticals	603.98M
Elite Pharmaceuticals	539.48M
Glass House Brands	414.24M
Northwest Biotherapeutics	378.71M
BioStem Technologies	261.80M

Market Cap Rankings